Poly Medicure Ltd

About Poly Medicure Ltd

Poly Medicure Ltd. is a leading Indian medical device manufacturer and exporter, specializing in a wide range of disposable healthcare products. The company focuses on innovative, safe, and quality medical devices across various therapeutic areas. With a strong R&D focus, POLYMED serves both domestic and international markets, holding a significant position in the medical consumables sector.

Key Financial Ratios of Poly Medicure Ltd

• P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Poly Medicure Ltd's P/E ratio (TTM) is 52.98, compared to the industry median of 55.27 and large cap median of 55.27.

• P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Poly Medicure Ltd's P/B ratio is 5.74, compared to the industry median of 4.08 and large cap median of 4.08.

• P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Poly Medicure Ltd's P/S ratio is 8.76, compared to the industry median of 1.80 and large cap median of 1.80.

• PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Poly Medicure Ltd's PEG ratio is 3.80.

• EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Poly Medicure Ltd's EV/EBITDA ratio is 29.23.

• Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Poly Medicure Ltd's ROE is 10.33%.

• Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Poly Medicure Ltd's ROA is 11.28%.

• Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Poly Medicure Ltd's ROCE is 14%.

• Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Poly Medicure Ltd's operating margin is 23.57%.

• Net Margin: Net margin shows what percentage of revenue converts into final net profit. Poly Medicure Ltd's net margin is 17.12%.

• Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Poly Medicure Ltd's current ratio is 1.83.

• Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Poly Medicure Ltd's debt-to-equity ratio is 0.02.

• Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Poly Medicure Ltd's interest coverage ratio is 24.72.

• Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Poly Medicure Ltd's DPS is ₹3.50.

• Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Poly Medicure Ltd's EPS is -4.88.

(Source line: "Ratios as of 28 Sept 2026, based on last traded price of ₹1756.40. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")

Key Facts

• Founded: 1984

• Headquarters: Faridabad, Haryana

• Core Offerings: Infusion Therapy, Anaesthesia, Urology, Dialysis, Blood Management

• Stock Listing: NSE (POLYMED), BSE (531768)

• Promoter: Himanshu Baid and Family

History of Poly Medicure Ltd

1984: Incorporated as Poly Medicure Ltd. 1986: Commenced commercial production. Early 2000s: Expanded product portfolio and initiated exports, building a global presence. 2005: Listed on NSE and BSE. 2010s onwards: Focused on R&D, product innovation, and expanding global manufacturing footprint (e.g., China, Egypt). Today, it is a prominent global player in medical consumables.

Business Segments and Revenue Mix

• Medical Devices: Poly Medicure operates primarily in the medical devices and disposables segment, manufacturing and distributing over 150 different products for various healthcare needs.

• Therapeutic Areas: Products span critical care, infusion therapy, blood management, urology, gastroenterology, dialysis, and vascular access.

• Manufacturing & R&D: The company boasts multiple state-of-the-art manufacturing facilities in India and abroad, with a strong emphasis on in-house R&D and product development to ensure high-quality and innovative offerings.

• Global Presence: POLYMED maintains a significant global footprint, serving over 110 countries with a substantial portion of its revenue derived from exports.

Key Personnel

Mr. Himanshu Baid: Chairman & Managing Director. A visionary entrepreneur with over three decades of experience in the medical technology sector, he has been instrumental in establishing POLYMED as a leading global player in disposable medical devices.

Subsidiaries and Associate Companies

• Poly Medicure (Shanghai) Co. Ltd., China

• Poly Medicure B.V., Netherlands

• Poly Medicure Healthcare LLC, USA

• Poly Medicure Inc., USA

• Poly Medicure Medical Devices Private Ltd., India

• Planters Polyclinic Private Limited, India

• Poly Medicure Aps, Denmark

• Poly Medicure Egypt S.A.E., Egypt

Corporate Actions

Bonus Issue: 1:2 in December 2023. Bonus Issue: 1:1 in December 2021. Rights Issue: 1:2 at Rs 350 per share in 2020. Acquisition of assets/business of Planters Polyclinic Private Limited in FY2023.

References

1. Annual Report FY23-24
2. Exchange Filings (NSE/BSE)
3. Investor Presentations
4. Company Website (polymedicure.com)